Evotec SE (ETR:EVT - Get Free Report)'s share price shot up 0.6% during mid-day trading on Thursday . The stock traded as high as €8.57 ($9.02) and last traded at €8.51 ($8.96). 562,056 shares were traded during mid-day trading, a decline of 59% from the average session volume of 1,360,000 shares. The stock had previously closed at €8.46 ($8.91).
Evotec Stock Down 1.3 %
The firm has a market cap of $1.62 billion, a P/E ratio of -9.44, a PEG ratio of 0.98 and a beta of 1.05. The firm has a fifty day moving average of €8.40 and a 200-day moving average of €7.50.
About Evotec
(
Get Free Report)
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Further Reading
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
